New test for the early detection of kidney cancer
Renal cell carcinoma (RCC) has poor survival because it does [...]
IKCS 2019: Biomarkers in kidney cancer
In this interview taken from the International Kidney Cancer Symposium [...]
Renal artery embolisation before surgery for large complex kidney tumours
Renal artery embolisation is sometimes performed before the surgical removal [...]
Small primary tumour size and prognosis
A recent study published in European Urology Oncology this month [...]
Treatment of favourable-risk metastatic kidney cancer
The treatment of patients with intermediate- and poor-risk metastatic renal [...]
Combination PD-1 and PD-L1 inhibitors for kidney cancer are no more beneficial than PD-1 inhibitor alone
A recent phase II clinical trial has shown that combined [...]
Real world use of targeted therapies in war veterans with kidney cancer
A retrospective study of the use of targeted therapies for [...]
Real world use of pazopanib after immunotherapy for advanced kidney cancer
A study published in Clinical Genitourinary Cancer last month describes [...]
Deciding on the ideal first-line treatment for rare and advanced kidney cancer
Currently, doctors are unsure which is the best first-line treatment [...]
SBRT in combination with systemic treatment for metastatic kidney cancer
Two recent studies have looked at the effect of stereotactic [...]
